QMDClass II
Transcranial Magnetic Stimulation System For Smoking Cessation
21 CFR 882.5802 / Neurology
QMD is the FDA product code for Transcranial Magnetic Stimulation System For Smoking Cessation, a class II device type, regulated under 21 CFR 882.5802. FDA's definition for this code reads: "Intended for use as a transcranial magnetic stimulation system for neurological and psychiatric disorders and conditions". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- QMD
- Device name
- Transcranial Magnetic Stimulation System For Smoking Cessation
- FDA definition
- Intended for use as a transcranial magnetic stimulation system for neurological and psychiatric disorders and conditions.
- Regulation
- 21 CFR 882.5802
- Device class
- Class II
- Review panel
- Neurology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code QMD
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
Applicants with the most clearances
Product code QMD| Applicant | Clearances |
|---|---|
| Brainsway Ltd. | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
